RAP 0.00% 20.5¢ raptor resources limited

Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-32

  1. 452 Posts.
    lightbulb Created with Sketch. 20
    Excellent on time update by ResApp on recruitment in "its SMARTCOUGH-C-2 study which remains on track to complete in the middle of this calendar year".
    Indicating an almost 100% quality assurance, strict study protocol, recordings.
    Great to hear that "incidence
    of the various diseases among study participants has been as expected which should ensure the study generates statistically strong results".
    I sense Team are highly confident to
    obtaining great results from the study in the middle of this calendar year and submitting the  "de novo application to the US Food and Drug Administration for the world’s first smartphone application for the digital diagnosis of respiratory disease shortly thereafter.

    Thumbs up
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.